Global Hospital-Acquired Infections Assays Market 2026 - Players, Regions, Product Types, Application & Forecast Analysis

Chapter 1 Hospital-Acquired Infections Assays Market Overview

1.1 Hospital-Acquired Infections Assays Definition

1.2 Global Hospital-Acquired Infections Assays Market Size Status and Outlook (2019-2032)

1.3 Global Hospital-Acquired Infections Assays Market Size Comparison by Region (2019-2032)

1.4 Global Hospital-Acquired Infections Assays Market Size Comparison by Type (2019-2032)

1.5 Global Hospital-Acquired Infections Assays Market Size Comparison by Application (2019-2032)

1.6 Global Hospital-Acquired Infections Assays Market Size Comparison by Sales Channel (2019-2032)

1.7 Hospital-Acquired Infections Assays Market Dynamics

1.7.1 Market Drivers/Opportunities

1.7.2 Market Challenges/Risks

1.7.3 Market News (Products Launch, Mergers, Acquisitions, Expansion, Agreement and Collaborations, Partnerships)

1.7.4 COVID-19 Impacts

1.7.5 Russia-Ukraine War Impacts

1.7.6 US-Israel-Iran War Impacts

Chapter 2 Executive Summary

2.1 Global Hospital-Acquired Infections Assays Market Snapshot

2.2 Global Hospital-Acquired Infections Assays Market Volume & Revenue (2019-2025)

2.3 Global Hospital-Acquired Infections Assays Market Differential Growth Potential Analysis by Type, (2019-2032) (USD Million)

2.4 Global Hospital-Acquired Infections Assays Market Differential Growth Potential Analysis by Application, (2019-2032) (USD Million)

2.5 Global Hospital-Acquired Infections Assays Market Differential Growth Potential Analysis by Sales Channels, (2019-2032) (USD Million)

2.6 Global Hospital-Acquired Infections Assays Market Differential Growth Potential Analysis by Region, (2019-2032) (USD Million)

Chapter 3 Hospital-Acquired Infections Assays Market Segment Analysis by Player

3.1 Global Hospital-Acquired Infections Assays Sales and Market Share by Player (2023-2025)

3.2 Global Hospital-Acquired Infections Assays Revenue and Market Share by Player (2023-2025)

3.3 Global Hospital-Acquired Infections Assays Average Price by Player (2023-2025)

3.4 Players Competition Situation & Trends (2023-2025)

3.5 Conclusion of Segment by Player

Chapter 4 Hospital-Acquired Infections Assays Market Segment Analysis by Type

4.1 Global Hospital-Acquired Infections Assays Market by Type

4.1.1 Blood Tests

4.1.2 Urinalysis

4.2 Global Hospital-Acquired Infections Assays Sales and Market Share by Type (2019-2025)

4.3 Global Hospital-Acquired Infections Assays Revenue and Market Share by Type (2019-2025)

4.4 Global Hospital-Acquired Infections Assays Average Price by Type (2019-2025)

4.5 Leading Players of Hospital-Acquired Infections Assays by Type in 2025

4.6 Conclusion of Segment by Type

Chapter 5 Hospital-Acquired Infections Assays Market Segment Analysis by Application

5.1 Global Hospital-Acquired Infections Assays Market by Application

5.1.1 Urinary Tract Infections

5.1.2 Pneumonia

5.1.3 Surgical Site Infections

5.1.4 Bloodstream Infections

5.1.5 Other Hospital Infections

5.2 Global Hospital-Acquired Infections Assays Revenue and Market Share by Application (2019-2025)

5.3 Leading Consumers of Hospital-Acquired Infections Assays by Application in 2025

5.4 Conclusion of Segment by Application

Chapter 6 Hospital-Acquired Infections Assays Market Segment Analysis by Sales Channel

6.1 Global Hospital-Acquired Infections Assays Market by Sales Channel

6.1.1 Global Hospital-Acquired Infections Assays Market, by Direct Channel Market Analysis (2019-2032) (USD Million)

6.1.2 Global Hospital-Acquired Infections Assays Market, by Distribution Channel Market Analysis (2019-2032) (USD Million)

6.2 Global Hospital-Acquired Infections Assays Revenue and Market Share by Sales Channel (2019-2025)

6.3 Leading Distributors/Dealers of Hospital-Acquired Infections Assays by Sales Channel in 2025

6.4 Conclusion of Segment by Sales Channel

Chapter 7 Hospital-Acquired Infections Assays Market Segment Analysis by Region

7.1 Global Hospital-Acquired Infections Assays Market Size and CAGR by Region (2019-2032)

7.2 Global Hospital-Acquired Infections Assays Sales and Market Share by Region (2019-2025)

7.3 Global Hospital-Acquired Infections Assays Revenue and Market Share by Region (2019-2025)

7.4 North America

7.4.1 North America Market by Country

7.4.2 North America Hospital-Acquired Infections Assays Market Share by Type

7.4.3 North America Hospital-Acquired Infections Assays Market Share by Application

7.4.4 United States

7.4.5 Canada

7.4.6 Mexico

7.5 Europe

7.5.1 Europe Market by Country

7.5.2 Europe Hospital-Acquired Infections Assays Market Share by Type

7.5.3 Europe Hospital-Acquired Infections Assays Market Share by Application

7.5.4 Germany

7.5.5 United Kingdom

7.5.6 France

7.5.7 Italy

7.5.8 Russia

7.5.9 Spain

7.5.10 Benelux

7.5.11 Poland

7.5.12 Austria

7.5.13 Portugal

7.5.14 Rest of Europe

7.6 Asia-Pacific

7.6.1 Asia-Pacific Market by Country

7.6.2 Asia-Pacific Hospital-Acquired Infections Assays Market Share by Type

7.6.3 Asia-Pacific Hospital-Acquired Infections Assays Market Share by Application

7.6.4 China

7.6.5 Japan

7.6.6 Korea

7.6.7 India

7.6.8 Southeast Asia

7.6.9 Australia

7.6.10 Taiwan

7.6.11 Rest of Asia Pacific

7.7 South America

7.7.1 South America Market by Country

7.7.2 South America Hospital-Acquired Infections Assays Market Share by Type

7.7.3 South America Hospital-Acquired Infections Assays Market Share by Application

7.7.4 Brazil

7.7.5 Argentina

7.7.6 Colombia

7.7.7 Chile

7.7.8 Peru

7.7.9 Venezuela

7.7.10 Rest of South America

7.8 Middle East & Africa

7.8.1 Middle East & Africa Market by Country

7.8.2 Middle East & Africa Hospital-Acquired Infections Assays Market Share by Type

7.8.3 Middle East & Africa Hospital-Acquired Infections Assays Market Share by Application

7.8.4 UAE

7.8.5 Saudi Arabia

7.8.6 South Africa

7.8.7 Egypt

7.8.8 Nigeria

7.9.9 Rest of Middle East & Africa

7.9 Conclusion of Segment by Region

Chapter 8 Profile of Leading Hospital-Acquired Infections Assays Players

8.1 BIOMÉRIEUX

8.1.1 Company Snapshot

8.1.2 Product/Service Offered

8.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.1.4 Recent Developments

8.2 Abbott

8.2.1 Company Snapshot

8.2.2 Product/Service Offered

8.2.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.2.4 Recent Developments

8.3 F. Hoffmann-La Roche Ltd.

8.3.1 Company Snapshot

8.3.2 Product/Service Offered

8.3.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.3.4 Recent Developments

8.4 Siemens Healthcare Private Limited

8.4.1 Company Snapshot

8.4.2 Product/Service Offered

8.4.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.4.4 Recent Developments

8.5 BD (Becton Dickinson and Company)

8.5.1 Company Snapshot

8.5.2 Product/Service Offered

8.5.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.5.4 Recent Developments

8.6 Bioscience Inc.

8.6.1 Company Snapshot

8.6.2 Product/Service Offered

8.6.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.6.4 Recent Developments

8.7 QIAGEN

8.7.1 Company Snapshot

8.7.2 Product/Service Offered

8.7.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.7.4 Recent Developments

8.8 Thermo Fisher Scientific Inc.

8.8.1 Company Snapshot

8.8.2 Product/Service Offered

8.8.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.8.4 Recent Developments

8.9 Meridian Bioscience Inc.

8.9.1 Company Snapshot

8.9.2 Product/Service Offered

8.9.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.9.4 Recent Developments

8.10 Hologic Inc.

8.10.1 Company Snapshot

8.10.2 Product/Service Offered

8.10.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)

8.10.4 Recent Developments

Chapter 9 Upstream and Downstream Analysis of Hospital-Acquired Infections Assays

9.1 Industrial Chain of Hospital-Acquired Infections Assays

9.2 Upstream of Hospital-Acquired Infections Assays

9.2.1 Raw Materials (If Applicable)

9.2.2 Manufacturing Cost Structure (If Applicable)

9.2.3 Manufacturing Process (If Applicable)

9.3 Downstream of Hospital-Acquired Infections Assays

9.3.1 Leading Distributors/Dealers of Hospital-Acquired Infections Assays

9.3.2 Leading Consumers of Hospital-Acquired Infections Assays

Chapter 10. Global Hospital-Acquired Infections Assays Market Industry Analysis

10.1. Porter's Five Forces Analysis

10.1.1. Threat of New Entrants

10.1.2. Bargaining Power of Buyers/Consumers

10.1.3. Bargaining Power of Suppliers

10.1.4. Threat of Substitute Types

10.1.5. Intensity of Competitive Rivalry

10.2. Major Growth Avenues within Global Hospital-Acquired Infections Assays Market

10.2.1. Product Types

10.2.2. Applications

10.2.3. Sales Channels

10.2.4. Country

10.3. Hospital-Acquired Infections Assays Industry Ecosystem

10.4. Price Trend Analysis (If Applicable)

10.5. Buying Criteria (If Applicable)

10.6. Regulations (If Applicable)

Chapter 11 Development Trend of Hospital-Acquired Infections Assays (2026-2032)

11.1 Global Hospital-Acquired Infections Assays Market Size (Sales and Revenue) Forecast (2026-2032)

11.2 Global Hospital-Acquired Infections Assays Market Size and CAGR Forecast by Region (2026-2032)

11.3 Global Hospital-Acquired Infections Assays Market Size and CAGR Forecast by Type (2026-2032)

11.4 Global Hospital-Acquired Infections Assays Market Size and CAGR Forecast by Application (2026-2032)

11.5 Global Hospital-Acquired Infections Assays Market Size and CAGR Forecast by Sales Channel (2026-2032)

Chapter 12. Import - Export Analysis (If Applicable)

12.1 North America Hospital-Acquired Infections Assays Import-Export (2019-2025)

12.2 Europe Hospital-Acquired Infections Assays Import-Export (2019-2025)

12.3 Asia Pacific Hospital-Acquired Infections Assays Import-Export (2019-2025)

12.4 South America Hospital-Acquired Infections Assays Import-Export (2019-2025)

12.5 Middle East & Africa Hospital-Acquired Infections Assays Import-Export (2019-2025)

Chapter 13. Demand-Supply Gap Analysis

13.1 North America Hospital-Acquired Infections Assays Demand-Supply (2019-2025)

13.2 Europe Hospital-Acquired Infections Assays Demand-Supply (2019-2025)

13.3 Asia Pacific Hospital-Acquired Infections Assays Demand-Supply (2019-2025)

13.4 South America Hospital-Acquired Infections Assays Demand-Supply (2019-2025)

13.5 Middle East & Africa Hospital-Acquired Infections Assays Demand-Supply (2019-2025)

Chapter 14 Appendix

14.1 Research Methodology

14.2 Data Sources